9960 logo

Renergen DB:9960 Stock Report

Last Price

€0.44

Market Cap

€68.4m

7D

7.8%

1Y

-22.5%

Updated

25 Nov, 2024

Data

Company Financials +

9960 Stock Overview

An investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. More details

9960 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Renergen Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Renergen
Historical stock prices
Current Share PriceR0.44
52 Week HighR0.88
52 Week LowR0.39
Beta0.86
11 Month Change-5.96%
3 Month Change-18.90%
1 Year Change-22.46%
33 Year Change-73.08%
5 Year Changen/a
Change since IPO-69.52%

Recent News & Updates

Recent updates

Shareholder Returns

9960DE Oil and GasDE Market
7D7.8%-1.6%0.2%
1Y-22.5%-36.9%8.5%

Return vs Industry: 9960 exceeded the German Oil and Gas industry which returned -36.9% over the past year.

Return vs Market: 9960 underperformed the German Market which returned 8.5% over the past year.

Price Volatility

Is 9960's price volatile compared to industry and market?
9960 volatility
9960 Average Weekly Movement7.9%
Oil and Gas Industry Average Movement5.5%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.9%
10% least volatile stocks in DE Market2.3%

Stable Share Price: 9960's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 9960's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
2005n/aStefano Maraniwww.renergen.co.za

Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. The company explores for, develops, and sells compressed natural gas, as well as liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which offers transportation of vaccines at low temperature without any electrical power.

Renergen Limited Fundamentals Summary

How do Renergen's earnings and revenue compare to its market cap?
9960 fundamental statistics
Market cap€68.37m
Earnings (TTM)-€7.09m
Revenue (TTM)€1.63m

42.0x

P/S Ratio

-9.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
9960 income statement (TTM)
RevenueR30.80m
Cost of RevenueR49.28m
Gross Profit-R18.48m
Other ExpensesR115.76m
Earnings-R134.24m

Last Reported Earnings

Aug 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.91
Gross Margin-59.99%
Net Profit Margin-435.79%
Debt/Equity Ratio79.3%

How did 9960 perform over the long term?

See historical performance and comparison